Mark Arnold Hagler, See Remarks at NovaBridge Biosciences (NBP), bought 230,000 shares at $2.51 ($577K) on 2026-04-24, disclosed to the SEC on 2026-04-28.
Mark Arnold Hagler purchased 230,000 shares of NovaBridge Biosciences for $577,300, representing the largest insider purchase in the company's history. This substantial buyback signals insider confidence in the stock's potential recovery following a recent 6.47% drop over the past month.
The stock is currently trading at $2.385, down 6.47% over the last 30 days and sitting 38.21% below its 52-week high of $3.86.
The trade represents the largest insider purchase in the company's history, signaling potential insider confidence in the stock's recovery trajectory.
The stock carries high volatility risk with a beta of 1.561, and the negative industry buying flow of -0.24% over the last 90 days suggests broader sector skepticism.
Nothing distinguishes this filing.